Assessing Guardant Health: Insights From 7 Financial Analysts
Assessing Guardant Health: Insights From 7 Financial Analysts
評估Guardant Health：來自7位財務分析師的見解
In the latest quarter, 7 analysts provided ratings for Guardant Health (NASDAQ:GH), showcasing a mix of bullish and bearish perspectives.
在最新的季度中，7位分析師爲Guardant Health（NASDAQ:GH）提供了評級，展示了看好和看淡的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.29, a high estimate of $44.00, and a low estimate of $28.00. This current average represents a 6.69% decrease from the previous average price target of $36.75.
分析師分析的12個月目標價提供了洞察力，平均目標爲34.29美元，高估爲44.00美元，低估爲28.00美元。這個目前的平均值相比之前的平均目標價36.75美元下降了6.69%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
A clear picture of Guardant Health's perception among financial experts is painted with a thorough...
通過對近期分析師行動的徹底分析，...
登入免費觀看全文
登入/註冊